Psychiatric referral and glycemic control of Egyptian type 2 diabetes mellitus patients with depression
Psychiatric referral and glycemic control of Egyptian type 2 diabetes mellitus patients with depression
复制标题
DOI:
10.1016/j.genhosppsych.2016.01.002
复制
发表时间:
2016-05-01
影响因子:
7
通讯作者:
Abdel-Moety, Hanaa
中科院分区:
文献类型:
--
作者:
Fawzi, Mounir H.;Said, Nagwa S.;Abdel-Moety, Hanaa
Objective: To evaluate the relationship between psychiatric referral acceptance for fluoxetine treatment and glycemic control in type 2 diabetes mellitus (T2DM) Egyptian patients with depression.Methods: Patients with T2DM who attended the diabetes outpatients clinic at Zagazig University Hospital, Egypt, between May 2013 and April 2015 and who scored >= 20 on screening with the Major Depression Inventory (MDI) (n=196) were offered a psychiatric referral for fluoxetine treatment and monitoring. Decliners (56.1%) received time/attention matched care via diabetologist visits (attentional controls). Fluoxetine patients and controls were compared at the time of the offer (T1) and 8 weeks later (T2). Factors that significantly correlated with glycemic control were used in a linear regression analysis as the independent variables.Results: Eighty-six patients (43.9%) accepted psychiatric referral. Most of them(97.7%) remained throughout the study adherent to fluoxetine (mean daily dose=31.9 mg). At T2, these patients, in comparison to controls, showed a reduction from baseline in MDI, fasting plasma glucose and glycosylated hemoglobin (HbA1c) levels (P for all comparisons